全球良性前列腺增生治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

良性攝護腺增生 (BPH) 治療市場規模預計將從 2025 年的 24.6 億美元成長到 2034 年的 55.3 億美元，2026 年至 2034 年的複合年成長率為 9.41%。

由於男性人口老化和攝護腺健康意識提升的提高，全球良性攝護腺增生（BPH）治療市場正穩定成長。診斷率的提高和泌尿系統醫療服務可近性的改善進一步推動了治療需求。藥物治療和微創手術持續受到關注，促進了已開發地區和新興地區市場的擴張。

關鍵成長要素包括微創手術技術的進步、聯合藥物療法的改進以及醫療保健支出的增加。患者越來越傾向於選擇恢復期較短的門診治療，這推動了醫療設備的普及。此外，加強宣傳活動和定期健康檢查也有助於早期診斷和提高患者對持續治療的接受度。

隨著醫療設備和藥物療法的不斷創新，未來前景依然樂觀。先進雷射治療和非侵入性治療方法的發展有望改善患者的治療效果。專注於提供經濟高效且以患者為中心的解決方案，並拓展新興市場業務的公司，可望穩步成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球良性攝護腺增生治療市場：依治療方法

• 市場分析、洞察與預測
• 微創手術
• 侵入性手術

第5章 全球良性攝護腺增生治療市場：依治療方法

• 市場分析、洞察與預測
• 經尿道前列腺切除術
• 攝護腺雷射手術
• 經尿道微波熱療
• 經尿道攝護腺針消融術
• 前列腺尿道提升術
• 蒸氣療法
• 機器人輔助腹腔鏡根治性攝護腺切除術
• 水磨療法
• 攝護腺動脈栓塞術
• 開腹攝護腺切除術
• 雙極攝護腺切除術
• 經尿道切口
• 高強度聚焦超音波

第6章 全球良性前列腺增生治療市場：依產品分類

• 市場分析、洞察與預測
• 電切鏡
• 泌尿系統雷射
• 射頻消融療法
• 電極
• 導管
• 攝護腺支架
• 植入
• 其他

第7章 全球良性攝護腺增生治療市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 專業設施
• 研究與製造

第8章 全球良性攝護腺增生治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Karl Storz
  • Boston Scientific Corporation
  • Olympus America
  • Endo Pharmaceuticals Inc
  • Biolitec AG
  • Medifocus
  • Cook Medical
  • Teleflex Incorporated
  • Urotronic
  • Coloplast Corp
  • Richard Wolf GmbH

The Benign Prostatic Hyperplasia Treatment Market size is expected to reach USD 5.53 Billion in 2034 from USD 2.46 Billion (2025) growing at a CAGR of 9.41% during 2026-2034.

The Global Benign Prostatic Hyperplasia Treatment Market is growing steadily due to the increasing aging male population and rising awareness of prostate health. Higher diagnosis rates and improved access to urological care have strengthened treatment demand. Pharmaceutical therapies and minimally invasive procedures continue to gain traction, contributing to market expansion across both developed and emerging regions.

Key drivers include technological advancements in minimally invasive surgical procedures, improved combination drug therapies, and rising healthcare spending. Greater patient preference for outpatient treatments with shorter recovery times is encouraging device adoption. Increased awareness campaigns and routine health screenings also contribute to early diagnosis and consistent treatment uptake.

Future prospects remain positive as innovation in medical devices and pharmacological treatments continues. Development of advanced laser therapies and non-invasive treatment options is expected to enhance patient outcomes. Companies focusing on cost-effective, patient-friendly solutions and expanding presence in emerging markets are likely to experience steady growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment

• Minimal Invasive Surgery
• Invasive Surgery

By Procedure

• Transurethral Resection Of The Prostate
• Prostate Laser Surgery
• Transurethral Microwave Thermotherapy
• Transurethral Needle Ablation Of The Prostate
• Prostatic Urethral Lift
• Water Vapor Therapy
• Robot-assisted Laparoscopic Prostatectomy
• Aquablation Therapy
• Prostatic Artery Embolization
• Open Prostatectomy
• Bipolar Enucleation Of Prostate
• Transurethral Incision Of The Prostate
• High-Intensity Focused Ultrasound

By Product

• Resectoscopes
• Urology Laser
• Radiofrequency Ablation
• Electrodes
• Catheters
• Prostatic Stents
• Implants
• Others

By End-use

• Hospitals
• Specialty Facilities
• Research & Manufacturing

COMPANIES PROFILED

• Karl Storz, Boston Scientific Corporation, Olympus America, Endo Pharmaceuticals Inc, biolitec AG, Medifocus, Cook Medical, Teleflex Incorporated, Urotronic, Coloplast Corp, Richard Wolf GmbH
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY TREATMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Treatment
• 4.2. Minimal Invasive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Invasive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Transurethral Resection Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Prostate Laser Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Transurethral Microwave Thermotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Transurethral Needle Ablation Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Prostatic Urethral Lift Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Water Vapor Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Robot-assisted Laparoscopic Prostatectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Aquablation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Prostatic Artery Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Open Prostatectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.12. Bipolar Enucleation Of Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.13. Transurethral Incision Of The Prostate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.14. High-Intensity Focused Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. Resectoscopes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Urology Laser Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Radiofrequency Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Electrodes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Prostatic Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Specialty Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research & Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Treatment
  • 8.2.2 By Procedure
  • 8.2.3 By Product
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Treatment
  • 8.3.2 By Procedure
  • 8.3.3 By Product
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Treatment
  • 8.4.2 By Procedure
  • 8.4.3 By Product
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Treatment
  • 8.5.2 By Procedure
  • 8.5.3 By Product
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Treatment
  • 8.6.2 By Procedure
  • 8.6.3 By Product
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Karl Storz
  • 10.2.2 Boston Scientific Corporation
  • 10.2.3 Olympus America
  • 10.2.4 Endo Pharmaceuticals Inc
  • 10.2.5 Biolitec AG
  • 10.2.6 Medifocus
  • 10.2.7 Cook Medical
  • 10.2.8 Teleflex Incorporated
  • 10.2.9 Urotronic
  • 10.2.10 Coloplast Corp
  • 10.2.11 Richard Wolf GmbH